Toxicity of cadmium in musculoskeletal diseases.
Cadmium
Osteoarthritis
Osteoporosis
Oxidative stress
Rheumatoid arthritis
Journal
Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
26
03
2019
revised:
19
06
2019
accepted:
25
06
2019
pubmed:
9
9
2019
medline:
17
3
2020
entrez:
9
9
2019
Statut:
ppublish
Résumé
Epidemiological studies have reported that exposure to toxic metals like cadmium (Cd) may promote the development of musculoskeletal diseases, such as osteoporosis, rheumatoid arthritis (RA), and osteoarthritis (OA), among others. The objective of this review is to summarize the molecular mechanisms of inflammation and oxidative stress activated by Cd at the bone level, particularly in osteoporosis, RA, and OA. Cadmium can increase bone resorption, affect the activity of osteoclasts and calcium (Ca) absorption, and impair kidney function, which favors the development of osteoporosis. In the case of RA, Cd interferes with the activity of antioxidant proteins, like superoxide dismutase (SOD) and catalase (CAT). It also promotes an inflammatory state, inducing the process of citrullination, which affects the proteins of immune response. On the other hand, accumulation of Cd in the tissues and blood of smokers has been related to the development of some musculoskeletal diseases. Therefore, knowing the negative impact of Cd toxicity at the articular level can help understand the damage mechanisms it produces, leading to the development of such diseases.
Identifiants
pubmed: 31494513
pii: S1382-6689(19)30090-0
doi: 10.1016/j.etap.2019.103219
pii:
doi:
Substances chimiques
Environmental Pollutants
0
Cadmium
00BH33GNGH
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103219Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.